Evidence map›Paper›PMID 38096888›Full record

SynthesisThe Lancet. Global health2024

Health system quality and COVID-19 vaccination: a cross-sectional analysis in 14 countries.

Catherine Arsenault, Todd P Lewis, Neena R Kapoor, Emelda A Okiro, Hannah H Leslie, Patrizio Armeni, Prashant Jarhyan, Svetlana V Doubova, Katherine D Wright, Amit Aryal and 15 more

Open access · goldAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in The Lancet. Global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Long COVID and the kidney.Nature reviews. Nephrology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Intrastate inequality of COVID-19 vaccination coverage: spatial analysis and socioeconomic, Santa Catarina, 2021-2023.Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 15 institutions in 11 countries.

Catherine ArsenaultDepartment of Global Health, Milken Institute School of Public Health, The George Washington University, Washington DC, USA. Electronic address: catherine.arsenault@gwu.edu.
Todd P LewisDepartment of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA.
Neena R KapoorDepartment of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA.
Emelda A OkiroPopulation & Health Impact Surveillance Group, KEMRI Wellcome Trust Research Programme, Nairobi, Kenya.
Hannah H LeslieDivision of Prevention Science, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
Patrizio ArmeniCERGAS SDA Bocconi School of Management, Bocconi University, Milan, Italy.
Prashant JarhyanPublic Health Foundation of India, Gurgaon, Haryana, India.
Svetlana V DoubovaEpidemiology and Health Services Research Unit CMN Siglo XXI, Mexican Institute of Social Security, Mexico City, Mexico.
Katherine D WrightDepartment of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA.
Amit AryalSwiss Tropical and Public Health Institute and University of Basel, Basel, Switzerland.
Sengchanh KounnavongLao Public Health Association, Ministry of Health, Vientiane, Laos.
Sailesh MohanPublic Health Foundation of India, Gurgaon, Haryana, India.
Emily OdipoPopulation & Health Impact Surveillance Group, KEMRI Wellcome Trust Research Programme, Nairobi, Kenya.
Hwa-Young LeeGraduate School of Public Health and Healthcare Management, The Catholic University of Korea, Seoul, South Korea.
Jeonghyun ShinDepartment of Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Wondimu AyeleSchool of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
Jesús Medina-RanillaFaculty of Public Health and Administration, Epidemiology Department, Universidad Peruana Cayetano Heredia, Lima, Peru.
Laura Espinoza-PajueloFaculty of Public Health and Administration, Epidemiology Department, Universidad Peruana Cayetano Heredia, Lima, Peru.
Anagaw Derseh MebratieSchool of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
Ezequiel García ElorrioInstitute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
Agustina MazzoniInstitute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
Juhwan OhDepartment of Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Gillian K SteelFisherDepartment of Health Policy and Management, Harvard T H Chan School of Public Health, Boston, MA, USA.
Rosanna TarriconeCERGAS SDA Bocconi School of Management, Bocconi University, Milan, Italy.
Margaret E KrukDepartment of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA.
Harvard Global Health Institute · USAddis Ababa University · ETBocconi University · ITInstituto de Efectividad Clínica y Sanitaria · ARKenya Medical Research Institute · KEPublic Health Foundation of India · INSeoul National University · KRUniversidad Peruana Cayetano Heredia · PECatholic University of Korea · KRHarvard University · USMexican Social Security Institute · MXMilken Institute · USMinistry of Health · LAUniversity of Basel · CHUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The social and behavioural determinants of COVID-19 vaccination have been described previously. However, little is known about how vaccinated people use and rate their health system. We used surveys conducted in 14 countries to study the health system correlates of COVID-19 vaccination. Country-specific logistic regression models were adjusted for respondent age, education, income, chronic illness, history of COVID-19, urban residence, and minority ethnic, racial, or linguistic group. Estimates were summarised across countries using random effects meta-analysis. Vaccination coverage with at least two or three doses ranged from 29% in India to 85% in Peru. Greater health-care use, having a regular and high-quality provider, and receiving other preventive health services were positively associated with vaccination. Confidence in the health system and government also increased the odds of vaccination. By contrast, having unmet health-care needs or experiencing discrimination or a medical mistake decreased the odds of vaccination. Associations between health system predictors and vaccination tended to be stronger in high-income countries and in countries with the most COVID-19-related deaths. Access to quality health systems might affect vaccine decisions. Building strong primary care systems and ensuring a baseline level of quality that is affordable for all should be central to pandemic preparedness strategies.

Indexed as

COVID-19VaccinesCOVID-19 VaccinesCross-Sectional StudiesHumansVaccinationCOVID-19 VaccinesVaccines

Identifiers

PMID38096888
PMCPMC10716622
OpenAlexW4389540331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.